Int J Med Sci 2019; 16(2):292-301. doi:10.7150/ijms.28047 This issue


Circular RNA: a novel biomarker and therapeutic target for human cancers

Bo Lei1,2, Zhiqiang Tian3, Weiping Fan2✉, Bing Ni1✉

1. Department of Pathophysiology, Third Military Medical University, Chongqing 400038, China
2. Department of Microbiology and Immunology, Shanxi Medical University, Taiyuan 030001, China
3. State Key Laboratory of Silkworm Genome Biology, Southwest University, Chongqing 400715, China

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license ( See for full terms and conditions.
Lei B, Tian Z, Fan W, Ni B. Circular RNA: a novel biomarker and therapeutic target for human cancers. Int J Med Sci 2019; 16(2):292-301. doi:10.7150/ijms.28047. Available from

File import instruction


Circular (circ)RNAs, a newly recognized class of noncoding RNA, have been implicated in the occurrence and development of several diseases, including neurological and cardiovascular diseases. Studies of human tumors, including those of liver cancer, gastric cancer, lung cancer and colorectal cancer, have shown differential expression profiles of circRNAs, suggesting regulatory roles in cancer pathogenesis and metastasis. In this review, we discuss the most recent research into tumor-related circRNAs, providing a comprehensive summary of the expression or/and function of these circRNAs and proposing rational perspectives on the potential clinical application of circRNAs as helpful biomarkers or therapeutic targets in human tumors.

Keywords: noncoding RNA, circRNA, cancer, biomarker, therapy